brinter.comCrawled Oct 15, 2026
Be a part of the next frontier in medical technology.
Brinter is a regenerative medicine company developing 3D-bioprinted implants and biofabrication technology.
Brinter develops bio-inductive, fully resorbable implants for tendon, ligament, cartilage, and reconstructive tissue repair. It is starting with rotator cuff, ACL, and Achilles repair and expanding into breast reconstruction and nasal implants.
Brinter successfully implants its first fully 3D-bioprinted regenerative implant in a live large-animal model at Colorado State University. The procedure, completed on October 6, marks a key milestone for the company’s rotator cuff implant and regenerative medicine field. The implant uses multi-material 3D-bioprinting technology to advance tissue regeneration.
Oct 2026BrinterNews article
BRINTER Inc. earns a spot on *TIME* magazine’s **Best Inventions of 2025** list for advancing **3D bioprinted tissue technology**. The Winston-Salem startup develops bioengineered tissues to accelerate medical research and regenerative medicine applications. This recognition highlights its innovation in a rapidly evolving biotech field.
Nov 2025ncbiotech.orgNews article
Brinter develops a 3D bioprinting system that constructs human tissue layers for medical research and regenerative applications. The technology enables precise, scalable fabrication of skin, cartilage, and vascular structures using bioinks and living cells. Researchers and clinicians explore its potential to accelerate tissue engineering and personalized treatment solutions.
Oct 2025TIMENews article
Brinter AM Technologies delivers a 3D bioprinter to the International Space Station (ISS) for the European Space Agency (ESA) to advance **Advanced Tissue Manufacturing**. The project studies **microgravity’s impact on human tissue**, aiming to support astronaut health in long-duration space missions and develop terrestrial medical applications.
Aug 2024BioSpaceNews article
